Summary

The global Intestinal Anti-infective Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Intestinal Anti-infective Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Intestinal Anti-infective Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Intestinal Anti-infective Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Intestinal Anti-infective Drugs players cover Botanic Healthcare, Medikonda Nutrients, Vox Nutrition, AdvaCare Pharma, Otto Chemie Pvt Ltd, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Intestinal Anti-infective Drugs Industry Forecast” looks at past sales and reviews total world Intestinal Anti-infective Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Intestinal Anti-infective Drugs sales for 2026 through 2032. With Intestinal Anti-infective Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intestinal Anti-infective Drugs industry.
This Insight Report provides a comprehensive analysis of the global Intestinal Anti-infective Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intestinal Anti-infective Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intestinal Anti-infective Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intestinal Anti-infective Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intestinal Anti-infective Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Intestinal Anti-infective Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Berberine
Rifaximin
Neomycin
Segmentation by Application:
Hospital
Clinic
Pharmacy
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Botanic Healthcare
Medikonda Nutrients
Vox Nutrition
AdvaCare Pharma
Otto Chemie Pvt Ltd
Teva Pharmaceuticals
Salix Pharmaceuticals
Hubei Hendi Pharmaceutical Co., Ltd.
Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
Jiangxi Pharmaceutical Co., Ltd.
Jilin Fukang Pharmaceutical Co., Ltd.
Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
Shandong Xinhua Pharmaceutical Co., Ltd.
Sichuan Ziligong Pharmaceutical Co., Ltd.
Yunnan Weihe Pharmaceutical Co., Ltd.
Tiansheng Pharmaceutical Group Co., Ltd.
Lingyuan Pharmaceutical Co., Ltd.
Jilin Jibang Pharmaceutical Co., Ltd.
Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
Chongqing Sino Biopharmaceutical Co., Ltd.
Yangzhou Sanyao Pharmaceutical Co., Ltd.
Chongqing Laimi Pharmaceutical Co., Ltd.
Nanjing Chengong Pharmaceutical Co., Ltd.
Hainan Hailing Chemical Pharmaceutical Co., Ltd.
Zhejiang Deer Pharmaceutical Co., Ltd.
Teyi Pharmaceutical Group Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intestinal Anti-infective Drugs market?
What factors are driving Intestinal Anti-infective Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intestinal Anti-infective Drugs market opportunities vary by end market size?
How does Intestinal Anti-infective Drugs break out by Type, by Application?

ページTOPに戻る

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intestinal Anti-infective Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Intestinal Anti-infective Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Intestinal Anti-infective Drugs by Country/Region, 2021, 2025 & 2032
2.2 Intestinal Anti-infective Drugs Segment by Type
2.2.1 Berberine
2.2.2 Rifaximin
2.2.3 Neomycin
2.2.4 Intestinal Anti-infective Drugs Sales by Type
2.2.4.1 Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Intestinal Anti-infective Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Intestinal Anti-infective Drugs Sale Price by Type (2021-2026)
2.3 Intestinal Anti-infective Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Pharmacy
2.3.4 Other
2.3.5 Intestinal Anti-infective Drugs Sales by Application
2.3.5.1 Global Intestinal Anti-infective Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Intestinal Anti-infective Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Intestinal Anti-infective Drugs Sale Price by Application (2021-2026)
3 Global by Company
3.1 Global Intestinal Anti-infective Drugs Breakdown Data by Company
3.1.1 Global Intestinal Anti-infective Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Intestinal Anti-infective Drugs Sales Market Share by Company (2021-2026)
3.2 Global Intestinal Anti-infective Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Intestinal Anti-infective Drugs Revenue by Company (2021-2026)
3.2.2 Global Intestinal Anti-infective Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Intestinal Anti-infective Drugs Sale Price by Company
3.4 Key Manufacturers Intestinal Anti-infective Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intestinal Anti-infective Drugs Product Location Distribution
3.4.2 Players Intestinal Anti-infective Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Intestinal Anti-infective Drugs by Geographic Region
4.1 World Historic Intestinal Anti-infective Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Intestinal Anti-infective Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Intestinal Anti-infective Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Intestinal Anti-infective Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Intestinal Anti-infective Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Intestinal Anti-infective Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Intestinal Anti-infective Drugs Sales Growth
4.4 APAC Intestinal Anti-infective Drugs Sales Growth
4.5 Europe Intestinal Anti-infective Drugs Sales Growth
4.6 Middle East & Africa Intestinal Anti-infective Drugs Sales Growth
5 Americas
5.1 Americas Intestinal Anti-infective Drugs Sales by Country
5.1.1 Americas Intestinal Anti-infective Drugs Sales by Country (2021-2026)
5.1.2 Americas Intestinal Anti-infective Drugs Revenue by Country (2021-2026)
5.2 Americas Intestinal Anti-infective Drugs Sales by Type (2021-2026)
5.3 Americas Intestinal Anti-infective Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intestinal Anti-infective Drugs Sales by Region
6.1.1 APAC Intestinal Anti-infective Drugs Sales by Region (2021-2026)
6.1.2 APAC Intestinal Anti-infective Drugs Revenue by Region (2021-2026)
6.2 APAC Intestinal Anti-infective Drugs Sales by Type (2021-2026)
6.3 APAC Intestinal Anti-infective Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intestinal Anti-infective Drugs by Country
7.1.1 Europe Intestinal Anti-infective Drugs Sales by Country (2021-2026)
7.1.2 Europe Intestinal Anti-infective Drugs Revenue by Country (2021-2026)
7.2 Europe Intestinal Anti-infective Drugs Sales by Type (2021-2026)
7.3 Europe Intestinal Anti-infective Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intestinal Anti-infective Drugs by Country
8.1.1 Middle East & Africa Intestinal Anti-infective Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Intestinal Anti-infective Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Intestinal Anti-infective Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Intestinal Anti-infective Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intestinal Anti-infective Drugs
10.3 Manufacturing Process Analysis of Intestinal Anti-infective Drugs
10.4 Industry Chain Structure of Intestinal Anti-infective Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intestinal Anti-infective Drugs Distributors
11.3 Intestinal Anti-infective Drugs Customer
12 World Forecast Review for Intestinal Anti-infective Drugs by Geographic Region
12.1 Global Intestinal Anti-infective Drugs Market Size Forecast by Region
12.1.1 Global Intestinal Anti-infective Drugs Forecast by Region (2027-2032)
12.1.2 Global Intestinal Anti-infective Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Intestinal Anti-infective Drugs Forecast by Type (2027-2032)
12.7 Global Intestinal Anti-infective Drugs Forecast by Application (2027-2032)
13 Key Players Analysis
13.1 Botanic Healthcare
13.1.1 Botanic Healthcare Company Information
13.1.2 Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.1.3 Botanic Healthcare Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Botanic Healthcare Main Business Overview
13.1.5 Botanic Healthcare Latest Developments
13.2 Medikonda Nutrients
13.2.1 Medikonda Nutrients Company Information
13.2.2 Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.2.3 Medikonda Nutrients Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Medikonda Nutrients Main Business Overview
13.2.5 Medikonda Nutrients Latest Developments
13.3 Vox Nutrition
13.3.1 Vox Nutrition Company Information
13.3.2 Vox Nutrition Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.3.3 Vox Nutrition Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Vox Nutrition Main Business Overview
13.3.5 Vox Nutrition Latest Developments
13.4 AdvaCare Pharma
13.4.1 AdvaCare Pharma Company Information
13.4.2 AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.4.3 AdvaCare Pharma Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 AdvaCare Pharma Main Business Overview
13.4.5 AdvaCare Pharma Latest Developments
13.5 Otto Chemie Pvt Ltd
13.5.1 Otto Chemie Pvt Ltd Company Information
13.5.2 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.5.3 Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Otto Chemie Pvt Ltd Main Business Overview
13.5.5 Otto Chemie Pvt Ltd Latest Developments
13.6 Teva Pharmaceuticals
13.6.1 Teva Pharmaceuticals Company Information
13.6.2 Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.6.3 Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Teva Pharmaceuticals Main Business Overview
13.6.5 Teva Pharmaceuticals Latest Developments
13.7 Salix Pharmaceuticals
13.7.1 Salix Pharmaceuticals Company Information
13.7.2 Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.7.3 Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Salix Pharmaceuticals Main Business Overview
13.7.5 Salix Pharmaceuticals Latest Developments
13.8 Hubei Hendi Pharmaceutical Co., Ltd.
13.8.1 Hubei Hendi Pharmaceutical Co., Ltd. Company Information
13.8.2 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.8.3 Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Hubei Hendi Pharmaceutical Co., Ltd. Main Business Overview
13.8.5 Hubei Hendi Pharmaceutical Co., Ltd. Latest Developments
13.9 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd.
13.9.1 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Company Information
13.9.2 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.9.3 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Latest Developments
13.10 Jiangxi Pharmaceutical Co., Ltd.
13.10.1 Jiangxi Pharmaceutical Co., Ltd. Company Information
13.10.2 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.10.3 Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Jiangxi Pharmaceutical Co., Ltd. Main Business Overview
13.10.5 Jiangxi Pharmaceutical Co., Ltd. Latest Developments
13.11 Jilin Fukang Pharmaceutical Co., Ltd.
13.11.1 Jilin Fukang Pharmaceutical Co., Ltd. Company Information
13.11.2 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.11.3 Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Jilin Fukang Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 Jilin Fukang Pharmaceutical Co., Ltd. Latest Developments
13.12 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd.
13.12.1 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Company Information
13.12.2 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.12.3 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Latest Developments
13.13 Fujian Sanming Tiantai Pharmaceutical Co., Ltd.
13.13.1 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Company Information
13.13.2 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.13.3 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Latest Developments
13.14 Shandong Xinhua Pharmaceutical Co., Ltd.
13.14.1 Shandong Xinhua Pharmaceutical Co., Ltd. Company Information
13.14.2 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.14.3 Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Shandong Xinhua Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Shandong Xinhua Pharmaceutical Co., Ltd. Latest Developments
13.15 Sichuan Ziligong Pharmaceutical Co., Ltd.
13.15.1 Sichuan Ziligong Pharmaceutical Co., Ltd. Company Information
13.15.2 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.15.3 Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Sichuan Ziligong Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Sichuan Ziligong Pharmaceutical Co., Ltd. Latest Developments
13.16 Yunnan Weihe Pharmaceutical Co., Ltd.
13.16.1 Yunnan Weihe Pharmaceutical Co., Ltd. Company Information
13.16.2 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.16.3 Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Yunnan Weihe Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Yunnan Weihe Pharmaceutical Co., Ltd. Latest Developments
13.17 Tiansheng Pharmaceutical Group Co., Ltd.
13.17.1 Tiansheng Pharmaceutical Group Co., Ltd. Company Information
13.17.2 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.17.3 Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Tiansheng Pharmaceutical Group Co., Ltd. Main Business Overview
13.17.5 Tiansheng Pharmaceutical Group Co., Ltd. Latest Developments
13.18 Lingyuan Pharmaceutical Co., Ltd.
13.18.1 Lingyuan Pharmaceutical Co., Ltd. Company Information
13.18.2 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.18.3 Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Lingyuan Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Lingyuan Pharmaceutical Co., Ltd. Latest Developments
13.19 Jilin Jibang Pharmaceutical Co., Ltd.
13.19.1 Jilin Jibang Pharmaceutical Co., Ltd. Company Information
13.19.2 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.19.3 Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Jilin Jibang Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Jilin Jibang Pharmaceutical Co., Ltd. Latest Developments
13.20 Shaanxi Kaiyuan Pharmaceutical Co., Ltd.
13.20.1 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Company Information
13.20.2 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.20.3 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Main Business Overview
13.20.5 Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Latest Developments
13.21 Chongqing Sino Biopharmaceutical Co., Ltd.
13.21.1 Chongqing Sino Biopharmaceutical Co., Ltd. Company Information
13.21.2 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.21.3 Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Chongqing Sino Biopharmaceutical Co., Ltd. Main Business Overview
13.21.5 Chongqing Sino Biopharmaceutical Co., Ltd. Latest Developments
13.22 Yangzhou Sanyao Pharmaceutical Co., Ltd.
13.22.1 Yangzhou Sanyao Pharmaceutical Co., Ltd. Company Information
13.22.2 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.22.3 Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Yangzhou Sanyao Pharmaceutical Co., Ltd. Main Business Overview
13.22.5 Yangzhou Sanyao Pharmaceutical Co., Ltd. Latest Developments
13.23 Chongqing Laimi Pharmaceutical Co., Ltd.
13.23.1 Chongqing Laimi Pharmaceutical Co., Ltd. Company Information
13.23.2 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.23.3 Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Chongqing Laimi Pharmaceutical Co., Ltd. Main Business Overview
13.23.5 Chongqing Laimi Pharmaceutical Co., Ltd. Latest Developments
13.24 Nanjing Chengong Pharmaceutical Co., Ltd.
13.24.1 Nanjing Chengong Pharmaceutical Co., Ltd. Company Information
13.24.2 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.24.3 Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Nanjing Chengong Pharmaceutical Co., Ltd. Main Business Overview
13.24.5 Nanjing Chengong Pharmaceutical Co., Ltd. Latest Developments
13.25 Hainan Hailing Chemical Pharmaceutical Co., Ltd.
13.25.1 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Company Information
13.25.2 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.25.3 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Main Business Overview
13.25.5 Hainan Hailing Chemical Pharmaceutical Co., Ltd. Latest Developments
13.26 Zhejiang Deer Pharmaceutical Co., Ltd.
13.26.1 Zhejiang Deer Pharmaceutical Co., Ltd. Company Information
13.26.2 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.26.3 Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Zhejiang Deer Pharmaceutical Co., Ltd. Main Business Overview
13.26.5 Zhejiang Deer Pharmaceutical Co., Ltd. Latest Developments
13.27 Teyi Pharmaceutical Group Co., Ltd.
13.27.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
13.27.2 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
13.27.3 Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Teyi Pharmaceutical Group Co., Ltd. Main Business Overview
13.27.5 Teyi Pharmaceutical Group Co., Ltd. Latest Developments
14 Research Findings and Conclusion

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Intestinal Anti-infective Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Intestinal Anti-infective Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Berberine
Table 4. Major Players of Rifaximin
Table 5. Major Players of Neomycin
Table 6. Global Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Intestinal Anti-infective Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Intestinal Anti-infective Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Intestinal Anti-infective Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global Intestinal Anti-infective Drugs Sale Market Share by Application (2021-2026)
Table 13. Global Intestinal Anti-infective Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global Intestinal Anti-infective Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global Intestinal Anti-infective Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Intestinal Anti-infective Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global Intestinal Anti-infective Drugs Sales Market Share by Company (2021-2026)
Table 18. Global Intestinal Anti-infective Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Intestinal Anti-infective Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global Intestinal Anti-infective Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Intestinal Anti-infective Drugs Producing Area Distribution and Sales Area
Table 22. Players Intestinal Anti-infective Drugs Products Offered
Table 23. Intestinal Anti-infective Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Intestinal Anti-infective Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Intestinal Anti-infective Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global Intestinal Anti-infective Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Intestinal Anti-infective Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Intestinal Anti-infective Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Intestinal Anti-infective Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global Intestinal Anti-infective Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Intestinal Anti-infective Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas Intestinal Anti-infective Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC Intestinal Anti-infective Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC Intestinal Anti-infective Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC Intestinal Anti-infective Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe Intestinal Anti-infective Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Intestinal Anti-infective Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Intestinal Anti-infective Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Intestinal Anti-infective Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Intestinal Anti-infective Drugs
Table 53. Key Market Challenges & Risks of Intestinal Anti-infective Drugs
Table 54. Key Industry Trends of Intestinal Anti-infective Drugs
Table 55. Intestinal Anti-infective Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Intestinal Anti-infective Drugs Distributors List
Table 58. Intestinal Anti-infective Drugs Customer List
Table 59. Global Intestinal Anti-infective Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Intestinal Anti-infective Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Intestinal Anti-infective Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Intestinal Anti-infective Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Intestinal Anti-infective Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Intestinal Anti-infective Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Intestinal Anti-infective Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Intestinal Anti-infective Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Intestinal Anti-infective Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Intestinal Anti-infective Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Intestinal Anti-infective Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Intestinal Anti-infective Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Botanic Healthcare Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Botanic Healthcare Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 75. Botanic Healthcare Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Botanic Healthcare Main Business
Table 77. Botanic Healthcare Latest Developments
Table 78. Medikonda Nutrients Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Medikonda Nutrients Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 80. Medikonda Nutrients Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Medikonda Nutrients Main Business
Table 82. Medikonda Nutrients Latest Developments
Table 83. Vox Nutrition Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Vox Nutrition Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 85. Vox Nutrition Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Vox Nutrition Main Business
Table 87. Vox Nutrition Latest Developments
Table 88. AdvaCare Pharma Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. AdvaCare Pharma Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 90. AdvaCare Pharma Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. AdvaCare Pharma Main Business
Table 92. AdvaCare Pharma Latest Developments
Table 93. Otto Chemie Pvt Ltd Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 95. Otto Chemie Pvt Ltd Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Otto Chemie Pvt Ltd Main Business
Table 97. Otto Chemie Pvt Ltd Latest Developments
Table 98. Teva Pharmaceuticals Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 100. Teva Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Teva Pharmaceuticals Main Business
Table 102. Teva Pharmaceuticals Latest Developments
Table 103. Salix Pharmaceuticals Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. Salix Pharmaceuticals Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 105. Salix Pharmaceuticals Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Salix Pharmaceuticals Main Business
Table 107. Salix Pharmaceuticals Latest Developments
Table 108. Hubei Hendi Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 110. Hubei Hendi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Hubei Hendi Pharmaceutical Co., Ltd. Main Business
Table 112. Hubei Hendi Pharmaceutical Co., Ltd. Latest Developments
Table 113. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 115. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Main Business
Table 117. Jiangxi Nanchang Jisheng Pharmaceutical Co., Ltd. Latest Developments
Table 118. Jiangxi Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 120. Jiangxi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Jiangxi Pharmaceutical Co., Ltd. Main Business
Table 122. Jiangxi Pharmaceutical Co., Ltd. Latest Developments
Table 123. Jilin Fukang Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 125. Jilin Fukang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Jilin Fukang Pharmaceutical Co., Ltd. Main Business
Table 127. Jilin Fukang Pharmaceutical Co., Ltd. Latest Developments
Table 128. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 130. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Main Business
Table 132. Dali Bai Autonomous Prefecture Traditional Chinese Medicine Pharmaceutical Co., Ltd. Latest Developments
Table 133. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 135. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Main Business
Table 137. Fujian Sanming Tiantai Pharmaceutical Co., Ltd. Latest Developments
Table 138. Shandong Xinhua Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 139. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 140. Shandong Xinhua Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Shandong Xinhua Pharmaceutical Co., Ltd. Main Business
Table 142. Shandong Xinhua Pharmaceutical Co., Ltd. Latest Developments
Table 143. Sichuan Ziligong Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 144. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 145. Sichuan Ziligong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. Sichuan Ziligong Pharmaceutical Co., Ltd. Main Business
Table 147. Sichuan Ziligong Pharmaceutical Co., Ltd. Latest Developments
Table 148. Yunnan Weihe Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 149. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 150. Yunnan Weihe Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. Yunnan Weihe Pharmaceutical Co., Ltd. Main Business
Table 152. Yunnan Weihe Pharmaceutical Co., Ltd. Latest Developments
Table 153. Tiansheng Pharmaceutical Group Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 154. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 155. Tiansheng Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Tiansheng Pharmaceutical Group Co., Ltd. Main Business
Table 157. Tiansheng Pharmaceutical Group Co., Ltd. Latest Developments
Table 158. Lingyuan Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 159. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 160. Lingyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Lingyuan Pharmaceutical Co., Ltd. Main Business
Table 162. Lingyuan Pharmaceutical Co., Ltd. Latest Developments
Table 163. Jilin Jibang Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 164. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 165. Jilin Jibang Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. Jilin Jibang Pharmaceutical Co., Ltd. Main Business
Table 167. Jilin Jibang Pharmaceutical Co., Ltd. Latest Developments
Table 168. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 169. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 170. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 171. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Main Business
Table 172. Shaanxi Kaiyuan Pharmaceutical Co., Ltd. Latest Developments
Table 173. Chongqing Sino Biopharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 174. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 175. Chongqing Sino Biopharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 176. Chongqing Sino Biopharmaceutical Co., Ltd. Main Business
Table 177. Chongqing Sino Biopharmaceutical Co., Ltd. Latest Developments
Table 178. Yangzhou Sanyao Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 179. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 180. Yangzhou Sanyao Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 181. Yangzhou Sanyao Pharmaceutical Co., Ltd. Main Business
Table 182. Yangzhou Sanyao Pharmaceutical Co., Ltd. Latest Developments
Table 183. Chongqing Laimi Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 184. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 185. Chongqing Laimi Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 186. Chongqing Laimi Pharmaceutical Co., Ltd. Main Business
Table 187. Chongqing Laimi Pharmaceutical Co., Ltd. Latest Developments
Table 188. Nanjing Chengong Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 189. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 190. Nanjing Chengong Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 191. Nanjing Chengong Pharmaceutical Co., Ltd. Main Business
Table 192. Nanjing Chengong Pharmaceutical Co., Ltd. Latest Developments
Table 193. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 194. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 195. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 196. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Main Business
Table 197. Hainan Hailing Chemical Pharmaceutical Co., Ltd. Latest Developments
Table 198. Zhejiang Deer Pharmaceutical Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 199. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 200. Zhejiang Deer Pharmaceutical Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 201. Zhejiang Deer Pharmaceutical Co., Ltd. Main Business
Table 202. Zhejiang Deer Pharmaceutical Co., Ltd. Latest Developments
Table 203. Teyi Pharmaceutical Group Co., Ltd. Basic Information, Intestinal Anti-infective Drugs Manufacturing Base, Sales Area and Its Competitors
Table 204. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Product Portfolios and Specifications
Table 205. Teyi Pharmaceutical Group Co., Ltd. Intestinal Anti-infective Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 206. Teyi Pharmaceutical Group Co., Ltd. Main Business
Table 207. Teyi Pharmaceutical Group Co., Ltd. Latest Developments


List of Figures
Figure 1. Picture of Intestinal Anti-infective Drugs
Figure 2. Intestinal Anti-infective Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intestinal Anti-infective Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Intestinal Anti-infective Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Intestinal Anti-infective Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Intestinal Anti-infective Drugs Sales Market Share by Country/Region (2025)
Figure 10. Intestinal Anti-infective Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Berberine
Figure 12. Product Picture of Rifaximin
Figure 13. Product Picture of Neomycin
Figure 14. Global Intestinal Anti-infective Drugs Sales Market Share by Type in 2026
Figure 15. Global Intestinal Anti-infective Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Intestinal Anti-infective Drugs Consumed in Hospital
Figure 17. Global Intestinal Anti-infective Drugs Market: Hospital (2021-2026) & (K Units)
Figure 18. Intestinal Anti-infective Drugs Consumed in Clinic
Figure 19. Global Intestinal Anti-infective Drugs Market: Clinic (2021-2026) & (K Units)
Figure 20. Intestinal Anti-infective Drugs Consumed in Pharmacy
Figure 21. Global Intestinal Anti-infective Drugs Market: Pharmacy (2021-2026) & (K Units)
Figure 22. Intestinal Anti-infective Drugs Consumed in Other
Figure 23. Global Intestinal Anti-infective Drugs Market: Other (2021-2026) & (K Units)
Figure 24. Global Intestinal Anti-infective Drugs Sale Market Share by Application (2025)
Figure 25. Global Intestinal Anti-infective Drugs Revenue Market Share by Application in 2026
Figure 26. Intestinal Anti-infective Drugs Sales by Company in 2026 (K Units)
Figure 27. Global Intestinal Anti-infective Drugs Sales Market Share by Company in 2026
Figure 28. Intestinal Anti-infective Drugs Revenue by Company in 2026 ($ millions)
Figure 29. Global Intestinal Anti-infective Drugs Revenue Market Share by Company in 2026
Figure 30. Global Intestinal Anti-infective Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Intestinal Anti-infective Drugs Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Intestinal Anti-infective Drugs Sales 2021-2026 (K Units)
Figure 33. Americas Intestinal Anti-infective Drugs Revenue 2021-2026 ($ millions)
Figure 34. APAC Intestinal Anti-infective Drugs Sales 2021-2026 (K Units)
Figure 35. APAC Intestinal Anti-infective Drugs Revenue 2021-2026 ($ millions)
Figure 36. Europe Intestinal Anti-infective Drugs Sales 2021-2026 (K Units)
Figure 37. Europe Intestinal Anti-infective Drugs Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Intestinal Anti-infective Drugs Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Intestinal Anti-infective Drugs Revenue 2021-2026 ($ millions)
Figure 40. Americas Intestinal Anti-infective Drugs Sales Market Share by Country in 2026
Figure 41. Americas Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2026)
Figure 42. Americas Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026)
Figure 43. Americas Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2026)
Figure 44. United States Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Intestinal Anti-infective Drugs Sales Market Share by Region in 2026
Figure 49. APAC Intestinal Anti-infective Drugs Revenue Market Share by Region (2021-2026)
Figure 50. APAC Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026)
Figure 51. APAC Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2026)
Figure 52. China Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. India Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Intestinal Anti-infective Drugs Sales Market Share by Country in 2026
Figure 60. Europe Intestinal Anti-infective Drugs Revenue Market Share by Country (2021-2026)
Figure 61. Europe Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026)
Figure 62. Europe Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2026)
Figure 63. Germany Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. France Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Intestinal Anti-infective Drugs Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Intestinal Anti-infective Drugs Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Intestinal Anti-infective Drugs Sales Market Share by Application (2021-2026)
Figure 71. Egypt Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Intestinal Anti-infective Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Intestinal Anti-infective Drugs in 2026
Figure 77. Manufacturing Process Analysis of Intestinal Anti-infective Drugs
Figure 78. Industry Chain Structure of Intestinal Anti-infective Drugs
Figure 79. Channels of Distribution
Figure 80. Global Intestinal Anti-infective Drugs Sales Market Forecast by Region (2027-2032)
Figure 81. Global Intestinal Anti-infective Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Intestinal Anti-infective Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Intestinal Anti-infective Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Intestinal Anti-infective Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Intestinal Anti-infective Drugs Revenue Market Share Forecast by Application (2027-2032)